v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Total
Beginning balance at Jun. 30, 2023 $ 1,000 $ 1,339,286 $ (329) $ (247,290) $ 1,092,667
Beginning balance (in Shares) at Jun. 30, 2023 [1] 10,714,286        
Net loss for the period (230,392) (230,392)
Foreign currency translation adjustments 2,502 2,502
Ending balance at Dec. 31, 2023 $ 1,000 1,339,286 2,173 (477,682) 864,777
Ending balance (in Shares) at Dec. 31, 2023 [1] 10,714,286        
Beginning balance at Jun. 30, 2024 $ 6,710,390 1,339,286 17,529 (1,102,217) 6,964,988
Beginning balance (in Shares) at Jun. 30, 2024 [1] 12,977,354        
Net loss for the period (6,109,608) (6,109,608)
Issuance of ordinary shares under 2024 equity incentive plan and 2025 equity incentive plan $ 225,000 225,000
Issuance of ordinary shares under 2024 equity incentive plan and 2025 equity incentive plan (in Shares) [1] 50,000        
Share-based compensation 2,887,926 2,887,926
Foreign currency translation adjustments 67,760 67,760
Ending balance at Dec. 31, 2024 $ 6,935,390 4,227,212 85,289 (7,211,825) 4,036,066
Ending balance (in Shares) at Dec. 31, 2024 [1] 13,027,354        
Beginning balance at Jun. 30, 2025 $ 33,104,858 8,973,101 67,114 (22,316,677) 19,828,396
Beginning balance (in Shares) at Jun. 30, 2025 [1] 22,169,854        
Net loss for the period (75,757,284) (75,757,284)
Issuance of ordinary shares under 2024 equity incentive plan and 2025 equity incentive plan $ 2,997,861 2,997,861
Issuance of ordinary shares under 2024 equity incentive plan and 2025 equity incentive plan (in Shares) [1] 139,308        
Share-based compensation 28,161,850 28,161,850
Issuance of ordinary shares under private placements $ 157,582,617 157,582,617
Issuance of ordinary shares under private placements (in Shares) [1] 16,600,000        
Issuance of warrants under private placements 30,159,183 30,159,183
Exercise of warrants $ 19,072,632 (6,665,511) 12,407,121
Exercise of warrants (in Shares) [1] 3,009,998        
Exercise of share options $ 2,394,677 (1,019,677) 1,375,000
Exercise of share options (in Shares) [1] 297,000        
Issuance of ordinary shares upon settlement of contingent consideration payable $ 29,768,075 29,768,075
Issuance of ordinary shares upon settlement of contingent consideration payable (in Shares) [1] 1,000,375        
Foreign currency translation adjustments (6,340) (6,340)
Ending balance at Dec. 31, 2025 $ 244,920,720 $ 59,608,946 $ 60,774 $ (98,073,961) $ 206,516,479
Ending balance (in Shares) at Dec. 31, 2025 [1] 43,216,535        
[1] Shares and per share data are presented on a retroactive basis to reflect the nominal share issuance and share split.